Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant Help Center Crisis
Powered By
Real members of myMPNteam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Saw this on media today, FDA approves BESREMI for treatment of ET

A myMPNteam Member asked a question 💭
Hudson, MA

https://www.instagram.com/p/DcwklKdlYT3/

HealthTree for MPNs on Instagram: "🩸 A new treatment option for essential thrombocythemia (ET) has arrived. The FDA has approved ropeginterferon alfa-2b-njft (Besremi) for adults with ET — the first new agent approved in the U.S. for ET since 1997. 🔎 What could this mean for ET treatment and care? And how does this approval build on Besremi’s previous approval for polycythemia vera (PV)? 👉 Read the full article to learn more about this important development. Link in Stories. #MPN #BloodCancer #FDAApproval #HealthTree"
HealthTree for MPNs on Instagram: "🩸 A new treatment option for essential thrombocythemia (ET) has arrived. The FDA has approved ropeginterferon alfa-2b-njft (Besremi) for adults with ET — the first new agent approved in the U.S. for ET since 1997. 🔎 What could this mean for ET treatment and care? And how does this approval build on Besremi’s previous approval for polycythemia vera (PV)? 👉 Read the full article to learn more about this important development. Link in Stories. #MPN #BloodCancer #FDAApproval #HealthTree"
https://www.instagram.com/p/DcwklKdlYT3/
September 1
 · 
Reactions
A myMPNteam Member

Earl, sorry—correction needed. I’m sure you didn’t mean to use the word “raise.” We want to LOWER the red blood cells in polycythemia Vera.

September 1
A myMPNteam Member

Also saw a new pill released to raise red cells without phlebotomist. Will locate the the URL and share later tonight.

September 1
myMPNteam

That's exciting news worth paying attention to! Besremi (ropeginterferon alfa-2b) is a form of interferon therapy that was already approved for polycythemia vera (PV), and an expanded approval for essential thrombocythemia (ET) would be a meaningful step forward for the MPN community.

Interferons work by boosting the Show Full Answer

That's exciting news worth paying attention to! Besremi (ropeginterferon alfa-2b) is a form of interferon therapy that was already approved for polycythemia vera (PV), and an expanded approval for essential thrombocythemia (ET) would be a meaningful step forward for the MPN community.

Interferons work by boosting the body's natural immune response to help control the overproduction of blood cells. Besremi is a self-injected medication, typically given under the skin. A myMPNteam member shared their own experience starting Besremi after hydroxyurea and phlebotomies stopped working for them, noting it was still early days but hopeful.

It's always worth bringing news like this to your hematologist or MPN specialist to discuss whether it could be a good fit for your specific situation and risk profile. They can help weigh the benefits against any potential side effects for you personally.

September 1

Related Questions

View All

Are there any drugs not chemo drugs

A myMPNteam Member asked a question 💭
London, UK
July 5

MPN Treatments and Effects on Quality of Life
Beyond Phlebotomy: Other Treatment Options for Polycythemia Vera
Getting Started on myMPNteam